Introduction
============

In recent years, stents play an increasingly essential part in pancreatic diseases such as plastic stents, self-expanding metal stents, biodegradable stents, radioactive particle stents and so on. As an example, the covered metal stents reduce the incidence of complications of biliary obstruction caused by pancreatic cancer. It has been reported that percutaneous insertion of short metal stents supplies for a secure treatment, which is beneficial for patients in resectable pancreatic head cancer with jaundice ([@ref-4]). With in-depth research, an irradiation pancreatic stent may provide longer patency and better patient survival ([@ref-48]). And endoscopic application significantly improves the therapeutic effect of pancreatic stent ([@ref-3]). Pancreatic cancer is a common digestive system cancer with high mortality. And the 5-year survival rate has increased from 3% to 8% over the past decade years ([@ref-44]; [@ref-38]). So far, surgical resection is the only possible treatment option. However, postoperative complications worsen the patient's prognosis and have been one of the leading causes of death after surgery. Multiple plastic stents or covered self-expandable metallic stent could relief bile duct stricture caused by chronic pancreatitis ([@ref-14]).

There have been few studies on the application of stents in pancreatic diseases by use of bibliometrics. Bibliometric method, as a quantitative analysis method, is used to determine the evolution of science exploration over the past decade years ([@ref-40]; [@ref-42]). Co-word analysis is an important scientometric method for identifying research hotspots in a certain field. Co-word analysis was proposed by French bibliographers in the 1970s. Its principle is mainly to count the frequency of simultaneous occurrence of words in the literature. The clustering analysis, association analysis, multi-dimensional scale analysis and other methods are utilized to analyze the relationship between words ([@ref-47]). Therefore, co-word analysis can be used to outline the current state of literature research in a field and to predict the future trends ([@ref-16]). Co-word analysis method reveals the intricate relationships between many objects in an intuitive way such as numerical values and graphics. Therefore, it can avoid the subjective problems brought by the previous reviews which were summarized by authors. Cluster analysis can be used to obtain semantic relationships for research topics ([@ref-7]). In our study, we made double-clustering analysis, which can cluster the rows and columns of a matrix simultaneously ([@ref-15]). Therefore, it can easily cluster global information and analyze high-dimensional data. The strategic diagram is used to describe the internal contact situation and the interaction between the fields in a research field based on the co-word matrix and clustering analysis, and further analyze the development of research hotspots in a certain subject. The strategic diagram displays the positional relationship of the clusters in the plane coordinates in a visual form. The quadrant structure and changes of the research subject are described according to the position and variation of the quadrant of the cluster.

Hence, we constructed a bibliometric analysis by co-word analysis and visualization concerning the application of stents in pancreatic diseases. And strategic diagram was established to explore the development status.

Materials and methods
=====================

Data obtaining
--------------

All publications came from PubMed without the restrictions of languages. The PubMed database has been used to retrieve data in some of the biomedical research ([@ref-24]; [@ref-22]). PubMed is chosen not only because of the authority and breadth of the literature, but also the normative nature of the Medical Subject Headings (MeSH) keywords, more importantly. MeSH has been applied to index and catalog articles in PubMed. In our study, we collected literature on the application of stents in pancreatic diseases on May 15th, 2018, in order to ensure more current research results. Our research strategy was as follows: ("stents"\[MeSH Terms\] OR "stents"\[All Fields\] OR "stent"\[All Fields\]) AND (("pancreas"\[MeSH Terms\] OR "pancreas"\[All Fields\] OR "pancreatic"\[All Fields\]) OR ("pancreatitis"\[MeSH Terms\] OR "pancreatitis"\[All Fields\])) and "2018/05/15" \[PDAT\]. Publication trends were retrieved from GoPubMed (<http://www.gopubmed.org>) ([@ref-9]).

Literature screening criteria
-----------------------------

If a paper concerning application of stents in pancreatic diseases was an original article, we would accept the literature. Meanwhile, media coverage and science briefings were excluded. Furthermore, two researchers separately examined the papers by title, abstract and full text. One researcher excluded 20 articles, and the other researcher excluded 19 articles. And the agreement was 95%, which suggested a strong correlation ([@ref-30]). Finally, title, author, institution, country, publication year and MeSH terms of available articles were saved into a new file in XML.

Data extraction and analysis
----------------------------

XML file was imported into BICOMB for data extraction ([@ref-8]; [@ref-18]; [@ref-27]). And authors, journals and the frequency ranking of MeSH terms were determined ([@ref-25]; [@ref-23]). According to the H index, the terms were first sorted in descending order of terms. Then the high-frequency major MeSH terms were identified if a term with frequency greater than or equal to its sequence number (h) from the list of high frequency terms, and h was the threshold for intercepting high frequency terms. Then, the relationships between the high-frequency major MeSH terms and the source literature were determined utilizing biclustering analysis. Also, a binary matrix was produced using the source literature set generated by BICOMB and the high-frequency MeSH terms as columns and rows.

Cluster analysis
----------------

Then, double clusters and visual analysis were performed by "gCLUTO" version 1.0 software. "gCLUTO" is a graphical cluster toolkit and graphical front-end of the "CLUTO" data clustering library ([@ref-20]; [@ref-28]). The clustering analysis was employed to assess the high-frequency MeSH terms. The clustering method was used to repeat the bisection, cosine as the similarity function, and I2 as the clustering criterion function. By use of different numbers of clusters, two clusters were performed to differentiate the first-rank number of clusters. And the visualizations of high frequency and high-frequency bifocal results with MeSH article were constructed by use of Alpine and Matrix. By means of the semantic corrections between the MeSH terms and the content of typical articles in every group, the relevant topics on the application of stents in pancreatic diseases were obtained. And we made a visualized matrix biclustering of high-frequent major MeSH terms and PubMed Unique Identifiers (PMIDs) of articles on the application of stents in pancreatic diseases.

Strategic diagram analysis
--------------------------

A two-dimensional table is depicted by plotting themes based on centricity and density. The *X*-axis stands for centrality, namely the closeness between keywords within this category and those within other categories. It indicates the degree of interaction between a subject area and other subject areas. The *Y*-axis represents density, namely the closeness of the keywords within each category. And it indicates that this category maintains and develops its own capabilities ([@ref-6]). The above eight categories were assigned to the four quadrants based on the results of the cluster analysis. In addition, excel was utilized to generate strategic diagram.

Social network analysis
-----------------------

The high frequency MeSH terms co-occurrence matrix was imported into the Ucinet 6.0 (Analytic Technologies Co., Lexington, KY, USA) software. And the social network analysis method was utilized to analyze the subject and knowledge structure of the application of stents in pancreatic diseases. Then the high-frequency MeSH term network was visualized by NetDraw 2.084 software. The nodes represent MeSH terms, and the links stand for the co-occurrence frequency of these terms. And we measured the degree, betweenness and closeness centralities of every node. At the same time, author relationship network was constructed by above methods.

Results
=======

Overall evaluation
------------------

Based on GoPubMed, we obtained the literature information according to the search strategy: stents \[MeSH\] and pancreas \[MeSH\] or "pancreatic diseases" \[MeSH\]. [Figure 1A](#fig-1){ref-type="fig"} depicts the distribution of the publication year of corresponding papers. The first article was published in 1977. As time went by, the volume of publications increased year by year. By 2015, it had a downward trend. [Figure 1B](#fig-1){ref-type="fig"} shows the volume of paper outputs concerning the application of stents in pancreatic diseases in the first 20 countries. And the map was generated by an online website ([pixelmap.amcharts.com](pixelmap.amcharts.com)). The number in the map is the quantity of associated publications for every country or region. The United States stands first with 1,167 publications. Furthermore, we summarized the annual distribution of MeSH terms associated with the application of stents in pancreatic diseases ([Fig. 1C](#fig-1){ref-type="fig"}). Different colors represent different highly frequent major MeSH terms. We found that these MeSH terms had roughly the same development trend every year from 1985-2018, indicating that they had close associations. As shown in [Table 1](#table-1){ref-type="table"}, the top 29 authors with a cumulative percentage of 27.9483 are listed. "Baron TH" (84, 2.0468%), "Kahaleh M" (81, 1.9737%) and "Isayama H" (65, 1.5838%) are the top three authors. From 1977 to 2018, the 25 most active journals published publications on the application of stents in pancreatic diseases account for 49.92% of all publications. [Table 2](#table-2){ref-type="table"} demonstrates the 25 most productive journals, as the core journals in the research fields on the application of stents in pancreatic diseases under Bradford's Law. "Gastrointestinal endoscopy", "Endoscopy", "World journal of gastroenterology" are the most active three journals.

![The information of literature on the application of stents in pancreatic diseases.\
(A) The growth of literature publications about the application of stents in pancreatic diseases from 1977 to 2018. (B) Geographic distribution of research outputs on the application of stents in pancreatic diseases. (C) Annual distribution of MeSH terms about the application of stents in pancreatic diseases.](peerj-07-7674-g001){#fig-1}
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###### The 29 top authors from the listed publications on the application of stents in pancreatic diseases (PubMed sourced until May 2018).

![](peerj-07-7674-g006)

  No.   Author           Frequency   Percentage, %[^a^](#table-1fn1){ref-type="fn"}   Cumulative percentage, %
  ----- ---------------- ----------- ------------------------------------------------ --------------------------
  1     Baron TH         84          2.0468                                           2.0468
  2     Kahaleh M        81          1.9737                                           4.0205
  3     Isayama H        65          1.5838                                           5.6043
  4     Itoi T           58          1.4133                                           7.0175
  5     Nakai Y          50          1.2183                                           8.2359
  6     Varadarajulu S   49          1.194                                            9.4298
  7     Sherman S        46          1.1209                                           10.5507
  8     Lehman GA        41          0.999                                            11.5497
  9     Costamagna G     39          0.9503                                           12.5
  10    Tada M           39          0.9503                                           13.4503
  11    Bhasin DK        38          0.9259                                           14.3762
  12    Koike K          37          0.9016                                           15.2778
  13    Rana SS          37          0.9016                                           16.1793
  14    Devière J        36          0.8772                                           17.0565
  15    Freeman ML       36          0.8772                                           17.9337
  16    Kogure H         36          0.8772                                           18.8109
  17    Kozarek RA       35          0.8528                                           19.6637
  18    Hirano K         32          0.7797                                           20.4435
  19    Ito K            31          0.7554                                           21.1988
  20    Wilcox CM        31          0.7554                                           21.9542
  21    Sasahira N       31          0.7554                                           22.7096
  22    Sasaki T         30          0.731                                            23.4405
  23    Huibregtse K     27          0.6579                                           24.0984
  24    Kim MH           27          0.6579                                           24.7563
  25    Yamamoto N       27          0.6579                                           25.4142
  26    Khashab MA       26          0.6335                                           26.0478
  27    Lee JH           26          0.6335                                           26.6813
  28    Gupta R          26          0.6335                                           27.3148
  29    Adler DG         26          0.6335                                           27.9483
        Total            1,147                                                        

**Notes.**

Proportion of the frequency among 1,147 times' appearance.

10.7717/peerj.7674/table-2

###### Most active journals on the topic of the application of stents in pancreatic diseases (PubMed sourced until May 2018).

![](peerj-07-7674-g007)

  No.   Top journals                                                                                                                       Publications n (%)
  ----- ---------------------------------------------------------------------------------------------------------------------------------- --------------------
  1     Gastrointestinal endoscopy                                                                                                         517 (12.55)
  2     Endoscopy                                                                                                                          339 (8.23)
  3     World journal of gastroenterology                                                                                                  107 (2.60)
  4     Surgical endoscopy                                                                                                                 101 (2.45)
  5     Digestive endoscopy: official journal of the Japan Gastroenterological Endoscopy Society                                           87 (2.11)
  6     The American journal of gastroenterology                                                                                           76 (1.85)
  7     Hepato-gastroenterology                                                                                                            76 (1.85)
  8     Cardiovascular and interventional radiology                                                                                        61 (1.48)
  9     Gastrointestinal endoscopy clinics of North America                                                                                61 (1.48)
  10    Digestive diseases and sciences                                                                                                    59 (1.43)
  11    JOP: Journal of the pancreas                                                                                                       51 (1.24)
  12    Journal of gastroenterology and hepatology                                                                                         51 (1.24)
  13    Journal of vascular and interventional radiology: JVIR                                                                             48 (1.17)
  14    Journal of gastrointestinal surgery: official journal of the Society for Surgery of the Alimentary Tract                           45 (1.09)
  15    Journal of clinical gastroenterology                                                                                               45 (1.09)
  16    Pancreas                                                                                                                           44 (1.07)
  17    Pancreatology: official journal of the International Association of Pancreatology (IAP) \... \[et al. \]                           40 (0.97)
  18    World journal of gastrointestinal endoscopy                                                                                        35 (0.85)
  19    Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association   33 (0.80)
  20    Gut                                                                                                                                33 (0.80)
  21    Endoscopic ultrasound                                                                                                              32 (0.78)
  22    HPB: the official journal of the International Hepato Pancreato Biliary Association                                                30 (0.73)
  23    Gan to kagaku ryoho. Cancer & chemotherapy                                                                                         29 (0.70)
  24    Journal of hepato-biliary-pancreatic sciences                                                                                      29 (0.70)
  25    Annals of surgery                                                                                                                  27 (0.66)
        Total                                                                                                                              2056(49.92)

High-frequent major MeSH terms
------------------------------

A total of 4,087 articles were selected until May 15th, 2018. Eighty-three high-frequency MeSH terms were extracted from the listed publications, with a cumulative percentage of 57.5291 ([Table 3](#table-3){ref-type="table"}). "Stents" (2238, 3.8488%), "Treatment Outcome" (1038, 1.7851%) and "Retrospective Studies" (758, 1.3036%) are the top three MeSH terms.

10.7717/peerj.7674/table-3

###### 83 High-frequent major MeSH terms from the listed publications on the application of stents in pancreatic diseases.

![](peerj-07-7674-g008)

  No.   Major MeSH[^a^](#table-3fn1){ref-type="fn"} terms/MeSH subheadings   Frequency, n   Percentage, %[^b^](#table-3fn2){ref-type="fn"}   Cumulative percentage, %
  ----- -------------------------------------------------------------------- -------------- ------------------------------------------------ --------------------------
  1     Stents                                                               2238           3.8488                                           13.9489
  2     Treatment Outcome                                                    1038           1.7851                                           27.731
  3     Retrospective Studies                                                758            1.3036                                           30.3725
  4     Cholangiopancreatography, Endoscopic Retrograde                      677            1.1643                                           31.5368
  5     Pancreatic Neoplasms/complications                                   544            0.9355                                           32.4723
  6     Follow-Up Studies                                                    472            0.8117                                           33.284
  7     Drainage/methods                                                     452            0.7773                                           34.0614
  8     Pancreatic Neoplasms/surgery                                         449            0.7722                                           34.8335
  9     Stents/adverse effects                                               401            0.6896                                           35.5231
  10    Cholestasis/etiology                                                 379            0.6518                                           36.1749
  11    Tomography, X-ray Computed                                           371            0.638                                            36.813
  12    Pancreatitis/etiology                                                338            0.5813                                           37.3942
  13    Cholangiopancreatography, Endoscopic Retrograde/adverse effects      335            0.5761                                           37.9704
  14    Cholangiopancreatography, Endoscopic Retrograde/methods              314            0.54                                             38.5104
  15    Prospective Studies                                                  297            0.5108                                           39.0211
  16    Pancreatic Ducts/surgery                                             295            0.5073                                           39.5284
  17    Time Factors                                                         289            0.497                                            40.0255
  18    Drainage                                                             281            0.4832                                           40.5087
  19    Palliative Care                                                      270            0.4643                                           40.973
  20    Endosonography                                                       254            0.4368                                           41.4099
  21    Cholestasis/therapy                                                  250            0.4299                                           42.2766
  22    Risk Factors                                                         244            0.4196                                           42.6962
  23    Pancreatic Neoplasms/pathology                                       238            0.4093                                           43.1055
  24    Cholestasis/surgery                                                  226            0.3887                                           43.4942
  25    Chronic Disease                                                      198            0.3405                                           43.8347
  26    Drainage/instrumentation                                             195            0.3354                                           44.17
  27    Metals                                                               185            0.3182                                           44.4882
  28    Pancreatic Ducts                                                     184            0.3164                                           44.8046
  29    Sphincterotomy, Endoscopic                                           182            0.313                                            45.1176
  30    Pancreatic Pseudocyst/surgery                                        182            0.313                                            45.4306
  31    Recurrence                                                           179            0.3078                                           45.7385
  32    Pancreatitis/complications                                           177            0.3044                                           46.0429
  33    Pancreatitis/surgery                                                 176            0.3027                                           46.3455
  34    Pancreatic Neoplasms/therapy                                         169            0.2906                                           46.6362
  35    Jaundice, Obstructive/etiology                                       164            0.282                                            46.9182
  36    Prosthesis Design                                                    164            0.282                                            47.2002
  37    Pancreatitis/prevention & control                                    164            0.282                                            47.4823
  38    Acute Disease                                                        163            0.2803                                           47.7626
  39    Equipment Design                                                     162            0.2786                                           48.0412
  40    Palliative Care/methods                                              158            0.2717                                           48.3129
  41    Bile Duct Neoplasms/complications                                    157            0.27                                             48.5829
  42    Pancreatitis/therapy                                                 151            0.2597                                           49.1057
  43    Endoscopy, Digestive System                                          150            0.258                                            49.3637
  44    Endoscopy, Digestive System/methods                                  146            0.2511                                           49.6148
  45    Survival Rate                                                        144            0.2476                                           49.8624
  46    Pancreas/surgery                                                     143            0.2459                                           50.1083
  47    Pancreatic Diseases/surgery                                          132            0.227                                            50.5692
  48    Cholangiopancreatography, Endoscopic Retrograde/instrumentation      131            0.2253                                           50.7945
  49    Pancreaticoduodenectomy                                              130            0.2236                                           51.0181
  50    Pancreatic Neoplasms/mortality                                       128            0.2201                                           51.2382
  51    Pancreatic Fistula/etiology                                          127            0.2184                                           51.4566
  52    Postoperative Complications                                          127            0.2184                                           51.675
  53    Endosonography/methods                                               125            0.215                                            51.89
  54    Prognosis                                                            125            0.215                                            52.105
  55    Pancreatic Ducts/pathology                                           122            0.2098                                           52.3148
  56    Pancreatic Neoplasms/diagnosis                                       121            0.2081                                           52.5229
  57    Endoscopy                                                            119            0.2047                                           52.7275
  58    Cholestasis, Extrahepatic/etiology                                   117            0.2012                                           52.9287
  59    Pancreatic Ducts/diagnostic imaging                                  116            0.1995                                           53.1282
  60    Pancreaticoduodenectomy/adverse effects                              115            0.1978                                           53.326
  61    Sphincterotomy, Endoscopic/methods                                   114            0.1961                                           53.522
  62    Constriction, Pathologic/therapy                                     114            0.1961                                           53.7181
  63    Pancreatic Pseudocyst/diagnostic imaging                             113            0.1943                                           53.9124
  64    Constriction, Pathologic/etiology                                    113            0.1943                                           54.1068
  65    Risk Assessment                                                      113            0.1943                                           54.3011
  66    Ultrasonography, Interventional                                      112            0.1926                                           54.4937
  67    Postoperative Complications/etiology                                 112            0.1926                                           54.6863
  68    Pancreatic Diseases/therapy                                          112            0.1926                                           54.8789
  69    Radiography                                                          110            0.1892                                           55.0681
  70    Pancreatic Pseudocyst/therapy                                        110            0.1892                                           55.2573
  71    Ampulla of Vater/surgery                                             110            0.1892                                           55.4464
  72    Pancreatic Neoplasms/diagnostic imaging                              109            0.1875                                           55.6339
  73    Ampulla of Vater                                                     109            0.1875                                           55.8214
  74    Jaundice, Obstructive/surgery                                        108            0.1857                                           56.0071
  75    Common Bile Duct Neoplasms/surgery                                   107            0.184                                            56.1911
  76    Adenocarcinoma/surgery                                               106            0.1823                                           56.3734
  77    Pancreatitis/diagnosis                                               101            0.1737                                           56.5471
  78    Constriction, Pathologic                                             101            0.1737                                           56.7208
  79    Diagnosis, Differential                                              97             0.1668                                           56.8876
  80    Postoperative Complications/epidemiology                             95             0.1634                                           57.051
  81    Constriction, Pathologic/surgery                                     94             0.1617                                           57.2126
  82    Cholestasis, Extrahepatic/therapy                                    92             0.1582                                           57.3708
  83    Pancreatitis, Chronic/complications                                  92             0.1582                                           57.5291

**Notes.**

MeSH: Medical Subject Headings

Proportion of the frequency among 19282 times' appearance.

![A mountain visualization biclustering of 83 high-frequent major MeSH terms and papers on the application of stents in pancreatic diseases.](peerj-07-7674-g002){#fig-2}

Cluster analysis
----------------

The double cluster analysis results were visualized into mountain visualization and hierarchical cluster tree. In the mountain visualization, the peak and matrix visualizations express the high-frequency MeSH terms. Each cluster represents a peak marked by cluster number 0--7 in [Fig. 2](#fig-2){ref-type="fig"}, and the related clusters are described according to the volume, color and height of the peaks. The volume of the peak is directly proportional to the number of MeSH terms in the cluster. Meanwhile, the internal standard deviation of a cluster object is represented by the color of the peak. Blue stands for the high deviation and red represents the low deviation. The peak is the position relative to the other clusters. The closer the distance between the two peaks, the higher the similarity between the two clusters. The height and similarity of each cluster are proportional to each other.

In [Fig. 3](#fig-3){ref-type="fig"}, the row labels represent high-frequency MeSH terms, and the PMIDs locate the column labels at the right and bottom of the matrix. The color of each grid suggests the frequency of appearance in a paper. The darker the red, the greater the frequency. Eighty-three high-frequency major MeSH terms are distinguished into eight clusters in matrix visualization. The top and left of the hierarchical tree respectively indicate the relationships among the major MeSH terms and the associations among the papers. Meanwhile, the corresponding article is obviously shown for each high frequency MeSH terms in each cluster.

![A visualized matrix biclustering of highly frequent major MeSH terms and PubMed Unique Identifiers (PMIDs) of articles on the application of stents in pancreatic diseases.](peerj-07-7674-g003){#fig-3}

Strategic diagram
-----------------

The centrality and density of the 8 clusters are listed in [Table 4](#table-4){ref-type="table"}. The details of MeSH terms and clusters are shown in [Table 5](#table-5){ref-type="table"}. In [Fig. 4](#fig-4){ref-type="fig"}, *x*-axis represents the centrality, and *y*-axis stands for the density on the strategy diagram. The four quadrants clockwise from the upper right corner express the first quadrant, the second quadrant, the third quadrant and the fourth quadrant. As shown in [Fig. 4A](#fig-4){ref-type="fig"}, the clusters in the first quadrant are suggested to be central topics in the network (due to their strong connection with other clusters) and have intense internal relationships (due to high degree of development). The clusters in the second quadrant are peripheral, however, already well-developed topic. The clusters in the third quadrant are both peripheral and undeveloped. The clusters in the fourth quadrant are central and undeveloped, but they are becoming mature to some extent ([@ref-19]).

[Figure 4B](#fig-4){ref-type="fig"} depicts that cluster 1 and cluster 3 are located in the first quadrant, suggesting that the cluster densities and centrality degrees are all high, that is to say, the MeSH terms in cluster 1 and cluster 3 are closely linked, and research tends to be well-developed. And the orientation is high, indicating that it is at the center of the research network. Cluster 4 and 7 are located in the second quadrant with high density and low centrality, indicating that internal links are close together with a clear topic. The research on this topic is shown to be relatively well-developed, with little correlation with other research. Cluster 0, 2 and 6 are located in the third quadrant, with low density and centrality. MeSH terms of Cluster 0, 2 and 6 are the margins of the entire field. The internal structure is relatively loose and research is yet developed. Cluster 5 is located in the fourth quadrant with low density and high centrality, indicating that it has close relations with other research. However, the research is not found to be well-developed. The research on this topic has potential value, and is now in the exploratory stage; however, more research is required.

10.7717/peerj.7674/table-4

###### The centrality and density of the 8 clusters.

![](peerj-07-7674-g009)

  Cluster   Intra-class link averages   Centrality-X   Intra-class link averages   Density-Y
  --------- --------------------------- -------------- --------------------------- -----------
  0         8.446666667                 −4.62712       33.16071429                 −22.7996
  1         15.29292929                 2.219142       75.47272727                 19.51241
  2         9.875586854                 −3.1982        31.62878788                 −24.3315
  3         24.98033126                 11.90654       98.67032967                 42.71001
  4         12.63963964                 −0.43415       68.26388889                 12.30357
  5         13.39589041                 0.322103       55.3                        −0.66032
  6         8.673972603                 −4.39982       27.58888889                 −28.3714
  7         11.28528529                 −1.7885        57.59722222                 1.636902
  total     13.07378775                                55.96031989                 

10.7717/peerj.7674/table-5

###### The cluster analysis of 8 clusters.

![](peerj-07-7674-g010)

  Cluster   Number of MeSH terms[^a^](#table-5fn1){ref-type="fn"}   Cluster analysis
  --------- ------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------
  0         23,34,56,58,69,72,79,82                                 Stents placement in pancreatic neoplasms
  1         5,9,10,19,21,24,27,36,39,40,41                          The complications of stents placement in bile duct neoplasms and pancreatic neoplasms
  2         8,35,45,49,50,52,54,71,73,74,75,76                      postoperative complications after stent placement such as pancreaticoduodenectomy
  3         1,2,3,6,11,15,17,18,46,47,51,60,67,80                   Stents for the prevention of pancreatic fistula following pancreaticoduodenectomy
  4         12,13,14,22,28,37,48,61,65                              <https://www.ncbi.nlm.nih.gov/pubmed/22185981> pancreatic duct stent can reduce the incidence of post-ERCP pancreatitis (PEP)
  5         4,25,29,31,32,33,38,42,57,77                            The diagnosis, surgery and therapy of pancreatitis
  6         16,43,55,59,62,64,68,78,81,83                           Pancreatic ducts changes in patients with chronic pancreatitis
  7         7,21,26,30,44,53,63,66,70                               Stent placement in endoscopic pancreatic pseudocyst drainage

**Notes.**

Represents the serial number of high-frequency MeSH terms.

![Strategic diagram for the application of stents in pancreatic diseases.\
(A) The meaning of strategic diagram. (B) The strategic diagram of the 8 clusters for the application of stents in pancreatic diseases.](peerj-07-7674-g004){#fig-4}

Social network analysis
-----------------------

As shown in [Fig. 5A](#fig-5){ref-type="fig"}, we constructed the author relationship network. There are 29 nodes which represent 29 authors. The size and location of nodes suggests the decisive role of an author. Links indicate the connection between two authors. In [Fig. 5A](#fig-5){ref-type="fig"}, the node "Itoi T" was the largest one, which was located in the center of the social network, followed by "Isayama H" and "Sasaki T". Therefore, these authors could play a critical role in the field of the application of stents in pancreatic diseases. Their articles could represent the maturity of the research area and hot spots. [Figure 5B](#fig-5){ref-type="fig"} depicts that the network relationships among 83 high-frequent major MeSH terms. The size of nodes suggests the centrality of high-frequent major MeSH terms. In the meanwhile, the thickness of the lines demonstrates the co-occurrence frequency of keywords pairs.

![Social network analysis.\
(A) The top 29 author relationship network. The size and location of nodes represent the centrality of an author in the social network. (B) The network of high-frequent major MeSH terms. Nodes suggest high-frequent major MeSH terms. The size and location of nodes represent the centrality of a MeSH term in the network structure map. Links stand for the connection between MeSH terms, and the number or thickness of the lines stands for the co-occurrence frequency of high-frequent major MeSH terms.](peerj-07-7674-g005){#fig-5}

Discussion
----------

We took advantage of GoPubMed to analyze the publication trends in the field of pancreatic stents. Before 2015, the volume of relevant publications was continuously rising and relative research interest was fluctuating rising. However, beginning with 2015, the volume of publications and relative research interest both showed a downward trend, which suggests that the researchers' interest have shifted and more innovation needs to be explored in the pancreatic stents. In addition, we also focused on the countries and author of research outputs. The United States, Japan and Germany remain to be the countries with the largest number of publications on pancreatic stents. The results indicated the developed countries occupied main position in the field. After measuring the top 29 authors on pancreatic stents, we made the author relationship network. The authors in the field have close cooperation, emphasizing the importance of cooperation. By paying attention to these authors, we would have a general understanding of the research direction and hotspots in this field. In order to further track research trends, journals are also the focus of attention. Therefore, we measured the most active journals, considering as the central journals in the relevant fields such as Gastrointestinal endoscopy, Endoscopy, World journal of gastroenterology. The high-frequency MeSH terms may reflect the research hot spots. The 83 high-frequency major MeSH terms were achieved by the co-occurrence in the same paper, which represented the research content in the field. Yearly distribution trends on different MeSH terms had the same fluctuating trend.

Eighty-three hot major MeSH terms were clustered into eight clusters. The network revealed that these MeSH terms existed complex relationship network. Endoscopic retrograde ERCP in acute and chronic pancreatitis and imaging methods as an auxiliary method of stent placement are located in the second quadrant. Cluster 1 and 3 are located in the first quadrant, including the complications of stent placement in bile duct neoplasms and pancreatic neoplasms and stents for the prevention of pancreatic fistula following pancreaticoduodenectomy. The two topics are current research center and hot topics for pancreatic stents. And cluster 0, 2, 6 are located in the third quadrant, which suggesting that the three topics are at the margin and not yet mature, including stents placement in pancreatic neoplasms, the postoperative complications after stent placement therapy such as pancreaticoduodenectomy and pancreatic ducts changes for patients in chronic pancreatitis. In the meanwhile, complications such as pancreatitis associated with stent implantation could have potential research value in the fourth quadrant, which are the research center, however, not yet mature. Therefore, the topic could become potential hotspots in the future science research. Then the 8 topics would be introduced respectively.

Stents placement in pancreatic neoplasms
----------------------------------------

Increasing numbers of patients with resectable pancreatic neoplasms are receiving neoadjuvant therapy such as stents placement. Tumor growth in pancreatic neoplasms often leads to invasion of other organs and biliary obstruction, resulting in repeated stent placement ([@ref-36]). The self-expandable metal stents possess effectiveness and safety in achieving durable biliary drainage for patients with pancreatic neoplasms ([@ref-1]; [@ref-17]). For example, the covered self-expanding metal stents is used for the therapy of biliary tract hemorrhage induced by advanced pancreatic cancer-induced portal biliary disease ([@ref-21]).

The complications of stent placement in bile duct neoplasms and pancreatic neoplasms
------------------------------------------------------------------------------------

As for pancreatic neoplasms, preoperative biliary drainage (PBD) promotes complications compared with surgery without PBD. The result could be associated with the plastic stents utilized. However, metal stents might decrease the PBD-associated complications ([@ref-43]). It has been confirmed that biliary stents could remarkably increase liver volume in both hilar and distal bile duct neoplasms ([@ref-26]). Endoscopic retrograde biliary drainage of metal bile duct stents are widely used for biliary obstruction. The application of bile duct stents has also led to an increasing number of complications. The main complications of pancreatic stents include migration, stent occlusion, and pancreatic ductal changes ([@ref-2]).

Postoperative complications after stent placement such as pancreaticoduodenectomy
---------------------------------------------------------------------------------

Pancreatic fistula is a leading complication following pancreaticoduodenectomy. [@ref-32] have reported that external pancreatic duct stent reduces pancreatic fistula rate following pancreaticoduodenectomy. Obstructive jaundice is one of the known risk factors for treatment failure following hepatectomy for patients with hilar cholangiocarcinoma. In palliative care, self-expanding metal stents have a rapid reduction in bile duct pressure and reduce complication rates, while providing patients with adequate and rapid biliary drainage ([@ref-13]).

Stents for the prevention of pancreatic fistula following pancreaticoduodenectomy
---------------------------------------------------------------------------------

It is necessary to prevent pancreatic fistula after pancreaticoduodenectomy in stent placement. The incidence of pancreatic fistula in patients undergoing pancreaticoduodenectomy is as high as 56% and is considered to be a main factor on morbidity and mortality in patients following pancreaticoduodenectomy ([@ref-10]; [@ref-5]). And external duct stents placement could reduce the occurrence for clinically relevant postoperative pancreatic fistula ([@ref-31]).

Prophylactic pancreatic duct stent can reduce the incidence of post-ERCP pancreatitis (PEP) and complications such as pancreatitis associated with stent implantation
---------------------------------------------------------------------------------------------------------------------------------------------------------------------

Endoscopic retrograde ERCP was first introduced in 1968. As a diagnostic tool, it was used to assess the disorders of pancreas ([@ref-33]). As a most common complication of ERCP, the incidence of PEP is still as high as 15% in high-risk cases ([@ref-11]). A small number of patients could develop severe pancreatitis. Pancreatitis is a common and serious complication for endoscopic retrograde ERCP. Prevention of pancreatitis after ERCP remains the focus of clinical and research. Relevant strategies could decrease the occurrence of post-ERCP pancreatitis including patient selection, risk stratification, surgical techniques, pancreatic stenting, and drug prophylaxis. Placement of the pancreatic stent is a relatively new and increasingly popular method of reducing the risk of pancreatitis after ERCP ([@ref-37]). Prophylactic pancreatic stent placement decreases the incidence of pancreatitis after ERCP in high risk patients and reduces the severity of this condition ([@ref-12]). In summary, placement for pancreatic duct stent decreases the incidence of pancreatitis ([@ref-39]).

Pancreatic duct changes in patients with chronic pancreatitis
-------------------------------------------------------------

It is essential to prevent pancreatic duct changes such as pancreatic leakage or pancreatic duct patency after pancreaticoduodenectomy. In duct-to-mucosa anastomosis, placement of the stent could be an effective mean of dilating the pancreatic duct  ([@ref-41]). Pancreatic stent is used to improve painful, obstructive chronic pancreatitis ([@ref-34]).

Stent placement in endoscopic pancreatic pseudocyst drainage
------------------------------------------------------------

Pancreatic pseudocyst is one of the common local complications of acute and chronic pancreatitis. And endoscopic pancreatic pseudocyst drainage has been widely applied in the treatment of pancreatic pseudocysts  ([@ref-29]). Endoscopic drainage has the advantages of small invasiveness, short recovery time, low cost and low complication rate ([@ref-35]), like interventional endoscopic ultrasonography has been increasingly used to manage pseudocyst formation ([@ref-46]). As an example, [@ref-45] have found that, compared with surgical bladder anastomosis, patients with endoscopy pancreatic pseudocyst drainage experience rarely recurrence of pseudocyst during follow-up.

Conclusion
==========

We analyzed the literature on pancreatic stents based on bibliometric analysis. Finally, 83 high-frequent MeSH terms and eight topics were found. And we found how to reduce the incidence of postoperative complications and improve the prognosis of patients with pancreatic diseases by stent implantation is still the focus of future research. This conclusion could provide potential and invaluable insight for researchers in the further research.
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